Respiratory syncytial virus infection activates IL-13–producing group 2 innate lymphoid cells through thymic stromal lymphopoietin

BACKGROUND: Respiratory syncytial virus (RSV) is a major health care burden with a particularly high worldwide morbidity and mortality rate among infants. Data suggest that severe RSV-associated illness is in part caused by immunopathology associated with a robust type 2 response. OBJECTIVE: We soug...

Descripción completa

Detalles Bibliográficos
Autores principales: Stier, Matthew T., Bloodworth, Melissa H., Toki, Shinji, Newcomb, Dawn C., Goleniewska, Kasia, Boyd, Kelli L., Quitalig, Marc, Hotard, Anne L., Moore, Martin L., Hartert, Tina V., Zhou, Baohua, McKenzie, Andrew N., Peebles, R. Stokes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mosby 2016
Materias:
Immune Deficiencies, Infection, and Systemic Immune Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014571/
https://www.ncbi.nlm.nih.gov/pubmed/27156176
http://dx.doi.org/10.1016/j.jaci.2016.01.050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014571/
https://www.ncbi.nlm.nih.gov/pubmed/27156176
http://dx.doi.org/10.1016/j.jaci.2016.01.050

Ejemplares similares